These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 9517411

  • 1. The AMPA-receptor antagonist YM90K reduces AMPA receptor-mediated excitotoxicity in rat hippocampal cultures.
    Ohno K, Okada M, Tsutsumi R, Sakamoto S, Yamaguchi T.
    Jpn J Pharmacol; 1998 Jan; 76(1):105-8. PubMed ID: 9517411
    [Abstract] [Full Text] [Related]

  • 2. Characterization of cyclothiazide-enhanced kainate excitotoxicity in rat hippocampal cultures.
    Ohno K, Okada M, Tsutsumi R, Matsumoto N, Yamaguchi T.
    Neurochem Int; 1998 Mar; 32(3):265-71. PubMed ID: 9587920
    [Abstract] [Full Text] [Related]

  • 3. Role of desensitization of AMPA receptors on the neuronal viability and on the [Ca2+]i changes in cultured rat hippocampal neurons.
    Ambrósio AF, Silva AP, Malva JO, Mesquita JF, Carvalho AP, Carvalho CM.
    Eur J Neurosci; 2000 Jun; 12(6):2021-31. PubMed ID: 10886341
    [Abstract] [Full Text] [Related]

  • 4. Characterization of YM90K, a selective and potent antagonist of AMPA receptors, in rat cortical mRNA-injected Xenopus oocytes.
    Okada M, Kohara A, Yamaguchi T.
    Eur J Pharmacol; 1996 Aug 15; 309(3):299-306. PubMed ID: 8874154
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neuropeptide Y release from cultured hippocampal neurons: stimulation by glutamate acting at N-methyl-D-aspartate and AMPA receptors.
    Gemignani A, Marchese S, Fontana G, Raiteri M.
    Neuroscience; 1997 Nov 15; 81(1):23-31. PubMed ID: 9300398
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In-vitro characterization of YM872, a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist.
    Kohara A, Okada M, Tsutsumi R, Ohno K, Takahashi M, Shimizu-Sasamata M, Shishikura J, Inami H, Sakamoto S, Yamaguchi T.
    J Pharm Pharmacol; 1998 Jul 15; 50(7):795-801. PubMed ID: 9720630
    [Abstract] [Full Text] [Related]

  • 9. Stereoselective neuroprotection by novel 2,3-benzodiazepine non-competitive AMPA antagonist against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures.
    May PC, Robison PM, Fuson KS.
    Neurosci Lett; 1999 Mar 12; 262(3):219-21. PubMed ID: 10218895
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Allosteric interactions between cyclothiazide and AMPA/kainate receptor antagonists.
    Yamada KA, Turetsky DM.
    Br J Pharmacol; 1996 Apr 12; 117(8):1663-72. PubMed ID: 8732274
    [Abstract] [Full Text] [Related]

  • 12. Neuroprotective effect of a novel AMPA receptor antagonist, YM90K, in rat focal cerebral ischaemia.
    Umemura K, Shimakura A, Nakashima M.
    Brain Res; 1997 Oct 31; 773(1-2):61-5. PubMed ID: 9409705
    [Abstract] [Full Text] [Related]

  • 13. Comparative antagonism of kainate-activated kainate and AMPA receptors in hippocampal neurons.
    Paternain AV, Vicente A, Nielsen EO, Lerma J.
    Eur J Neurosci; 1996 Oct 31; 8(10):2129-36. PubMed ID: 8921304
    [Abstract] [Full Text] [Related]

  • 14. Complestatin is a noncompetitive peptide antagonist of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors: secure blockade of ischemic neuronal death.
    Seo SY, Yun BS, Ryoo IJ, Choi JS, Joo CK, Chang SY, Chung JM, Oh S, Gwag BJ, Yoo ID.
    J Pharmacol Exp Ther; 2001 Oct 31; 299(1):377-84. PubMed ID: 11561102
    [Abstract] [Full Text] [Related]

  • 15. Selective protection against AMPA- and kainate-evoked neurotoxicity by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisoquinoline- 3-carboxylic acid (LY293558) and its racemate (LY215490).
    Schoepp DD, Salhoff CR, Fuson KS, Sacaan AI, Tizzano JP, Ornstein PL, May PC.
    J Neural Transm (Vienna); 1996 Oct 31; 103(8-9):905-16. PubMed ID: 9013384
    [Abstract] [Full Text] [Related]

  • 16. Effects of YM90K, a selective AMPA receptor antagonist, on amygdala-kindling and long-term hippocampal potentiation in the rat.
    Kodama M, Yamada N, Sato K, Kitamura Y, Koyama F, Sato T, Morimoto K, Kuroda S.
    Eur J Pharmacol; 1999 Jun 11; 374(1):11-9. PubMed ID: 10422635
    [Abstract] [Full Text] [Related]

  • 17. Allosteric regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines.
    Donevan SD, Rogawski MA.
    Neuroscience; 1998 Dec 11; 87(3):615-29. PubMed ID: 9758228
    [Abstract] [Full Text] [Related]

  • 18. Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures.
    Kristensen BW, Noraberg J, Zimmer J.
    Brain Res; 2001 Oct 26; 917(1):21-44. PubMed ID: 11602227
    [Abstract] [Full Text] [Related]

  • 19. The glutamate receptor/NO/cyclic GMP pathway in the hippocampus of freely moving rats: modulation by cyclothiazide, interaction with GABA and the behavioural consequences.
    Fedele E, Conti A, Raiteri M.
    Neuropharmacology; 1997 Oct 26; 36(10):1393-403. PubMed ID: 9423927
    [Abstract] [Full Text] [Related]

  • 20. Kainate excitotoxicity is mediated by AMPA- but not kainate-preferring receptors in embryonic rat hippocampal cultures.
    Ohno K, Okada M, Tsutsumi R, Kohara A, Yamaguchi T.
    Neurochem Int; 1997 Nov 26; 31(5):715-22. PubMed ID: 9364457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.